Callisto Pharmaceuticals
Craig C. Talluto, Ph.D., ABD, has served as their Senior Director, Clinical Operations at Callisto since August 2006. Craig has over 10 years of broad pharmaceutical industry experience as an independent contractor working with clients in all phases of clinical trial development for both therapeutic and diagnostic product candidates. These clients included Amgen, Hoffman-La Roche and Kos Pharmaceuticals. Craig completed his residency and earned his Ph.D. in Physiology for Sport Science, with a supporting field in Clinical Immunology, from the University of Miami. Craig’s dissertation examined the effects of aerobic and resistance training on male respiratory physiology. He earned his Master of Science with a major in Exercise Physiology and his Bachelor of Science with a major in Marketing and Business Administration from the University of New Orleans.
This person is not in any offices
Callisto Pharmaceuticals
Callisto Pharmaceuticals is a public biotechnology company that develops novel therapeutics to treat cancer.